MIR-539 inhibits FSCNl expression and suppresses hepatocellular carcinoma migration and invasion

Increasing evidence indicates that the dysregulation of miRNAs that act as tumor suppressors or oncogenes is involved in tumorigenesis. However, the role of MIR-539 in hepatocellular carcinoma (HCC) has not been well investigated. Quantitative RT-PCR (qRT-PCR), proliferation assay, colony formation assay, migration and invasion assays, western blotting, and xenograft tumor growth models were performed to assess the expression levels and functions of MIR-539 in HCC. Luciferase reporter assays, qRT-PCR, western blotting, and immunohistochemistry were used to identify and verify the targets of MIR-539. MIR-539 was significantly downregulated in HCC cell lines and tissue samples. Ectopic expression of MIR-539 inhibited cell viability, proliferation, migration, and invasion in vitro and suppressed xenograft tumor growth in vivo. Fascin homologue 1 (FSCNl) was verified as a direct target of MIR-539, and overexpression of FSCNl promoted HCC cell migration and invasion. MIR-539 acts as a novel tumor suppressor in the development and progression of HCC by targeting FSCNl, providing new insight into the mechanisms of HCC carcinogenesis and suggesting that MIR-539 may be a therapeutic target.